Table 5 Comparison of clinicopathological features of VI-RADS≧4 and ≦3 by Reader2
From: Determining the clinicopathological significance of the VI-RADS ≧4 group: a retrospective study
Variable | Total (n = 121) | VI-RADS≧4 (n = 32) | VI-RADS≦3 (n = 89) | VI-RADS≧4 vs VI-RADS≦3 | |
|---|---|---|---|---|---|
Univariate analysis | |||||
P = value | OR (95%CI) | ||||
Mean age (yr) | 72.7 | 75.6 | 71.7 | 0.145 | (-0.09–0.27) |
Sex (n) | |||||
Male | 103 | 24 | 79 | 0.166 | 2.04 |
Female | 18 | 8 | 10 | (0.73–5.68) | |
Tumor size (n) | |||||
Tumor mean size (mm) | 19.8 | 31.8 | 15.5 | < 0.001 | (0.42–0.68) |
< 3 cm | 98 | 16 | 82 | < 0.001 | 31.77 |
≧3 cm | 23 | 16 | 7 | (8.47–119.07) | |
Number of tumors (n) | |||||
Single | 100 | 29 | 71 | 0.165 | 0.41 |
Multiple | 21 | 3 | 18 | (0.11–1.49) | |
Urine cytology (n) | |||||
≦ ClassIII | 86 | 18 | 68 | 0.031 | 2.52 |
≧ ClassIV | 35 | 14 | 21 | (1.07–5.91) | |
Histology grade (n) | |||||
Low (G1 or G2) | 51 | 2 | 49 | < 0.001 | 18.38 |
High (G3) | 70 | 30 | 40 | (4.14–81.62) | |
CIS (n) | |||||
( +) | 15 | 4 | 11 | 0.984 | 1.01 |
( −) | 106 | 28 | 78 | (0.30–3.44) | |
Tumor necrosis (n) | |||||
( +) | 19 | 12 | 7 | < 0.001 | 7.46 |
( −) | 102 | 20 | 82 | (2.61–21.34) | |
UC Variant (n) | |||||
( +) | 16 | 8 | 8 | 0.022 | 3.38 |
( −) | 105 | 24 | 81 | (1.15–9.95) | |